Quick answer
What is KPV?
Built from index records dated 2026-10-09 to 2026-10-13 Compiled by an automated pipeline, checked by The Peptide Observer editorial desk How this site works
KPV is a peptide, grouped on this site under Tissue repair peptides, and the 12 research records kept here are 8 from studies in rats or mice and 4 that do not state what kind of study it is.
The literature search returned 118 records. This site keeps 12 of them, which is 10 per cent of what came back.
What it is
This site puts it in the Tissue repair peptides group.
The C-terminal tripeptide of alpha-MSH; the retrieved records report anti-inflammatory activity and PepT1-mediated uptake in intestinal epithelium.[1, 2]
Stated in the titles of the cited 2008 Gastroenterology and 2008 Inflammatory Bowel Diseases papers.
What kind of records
The records kept here are animal and laboratory studies only.
That sentence is produced by counting, not by reading. What was counted: no interventional human trial record; 8 rodent and 0 in vitro records among 12.
What this does not settle
- What it does in a body. Counting records is not reading them, and nothing here has been read in full.
- Whether it causes harm. No adverse-effect row was taken from any source for this entry.
- How long it lasts. No pharmacokinetics source was retrieved for this entry.
- What the other 106 retrieved records say. They are not in this index.
The longer explanation
Where this comes from
The records cited above, in full.
- PepT1-mediated tripeptide KPV uptake reduces intestinal inflammation. Gastroenterology (2008). pmid:18061177
- Melanocortin-derived tripeptide KPV has anti-inflammatory potential in murine models of inflammatory bowel disease. Inflammatory bowel diseases (2008). pmid:18092346